Related Experiment Video
Updated: Nov 10, 2025
09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
3.1K
Thrombocytopenia: Effect in Ischemic and Hemorrhagic Stroke
Dimensions of Critical Care Nursing : DCCN
|April 1, 2021
Summary
Platelets are crucial in stroke development and progression. Low platelet counts (thrombocytopenia) can cause ischemic strokes or increase bleeding risks, impacting stroke care.
Area of Science:
- Neuroscience
- Hematology
- Pathophysiology
Background:
- Strokes are classified as ischemic (clot-caused) or hemorrhagic (vessel rupture).
- Platelets play a key role in clot formation, blood flow obstruction, and stroke progression.
- Thrombocytopenia (low platelet count) influences stroke causation and complications.
Purpose of the Study:
- To elucidate the role of platelets in acute stroke pathophysiology.
- To examine stroke processes affected by thrombocytopenia.
- To highlight the impact of platelet function on stroke care.
Main Methods:
- Review of a case study demonstrating platelet involvement in stroke.
- Analysis of how autoimmune thrombocytopenia affects stroke aspects.
Main Results:
- Platelets are integral to both ischemic and hemorrhagic stroke development.
- Thrombocytopenia can be a direct cause of ischemic stroke.
- Thrombocytopenia increases the risk of hemorrhagic stroke and conversion.
Conclusions:
- Thrombocytopenia is an under-recognized factor in stroke care.
- It can precipitate strokes and lead to bleeding complications.
- Understanding platelet and thrombocytopenia impact is vital for comprehensive stroke management.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.2K
01:24Disorders of Hemostasis
1.5K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.5K
01:05Introduction to Hemostasis
11.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
11.5K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
10.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.6K
01:16Clot Retraction and Fibrinolysis
7.7K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.7K
01:22Formation of the Platelet Plug
8.0K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.0K